Litcius/Paper detail

Serum type I interferon score as a disease activity biomarker in patients with diffuse cutaneous systemic sclerosis: a retrospective cohort study

Monique Hinchcliff, Dinesh Khanna, Enrico De Lorenzis, Stefano Di Donato, Antonio Carriero, Rebecca L. Ross, Suiyuan Huang, Kathleen Aren, Elana J. Bernstein, Mary Carns, Flavia V. Castelino, Robyn T. Domsic, Tracy Frech, Jessica Gordon, Faye N. Hant, Ami A. Shah, Victoria K. Shanmugam, Virginia Steen, Shervin Assassi, Francesco Del Galdo

2025The Lancet Rheumatology14 citationsDOIOpen Access PDF

Topics & Concepts

MedicineBiomarkerRetrospective cohort studyCohortMultiple sclerosisInternal medicineDiseaseCohort studySystemic diseaseOncologyImmunologyBiochemistryChemistrySystemic Sclerosis and Related DiseasesInflammatory Myopathies and DermatomyositisMultiple Sclerosis Research Studies
Serum type I interferon score as a disease activity biomarker in patients with diffuse cutaneous systemic sclerosis: a retrospective cohort study | Litcius